On Monday, XOMA Royalty Corp (NASDAQ: XOMA) was -10.25% drop from the session before settling in for the closing price of $29.85. A 52-week range for XOMA has been $18.35 – $39.92.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -48.78%. When this article was written, the company’s average yearly earnings per share was at 171.97%. With a float of $12.14 million, this company’s outstanding shares have now reached $12.31 million.
XOMA Royalty Corp (XOMA) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward XOMA Royalty Corp stocks. The insider ownership of XOMA Royalty Corp is 1.93%, while institutional ownership is 67.53%. The most recent insider transaction that took place on Dec 04 ’25, was worth 2,505,000. In this transaction Chief Executive Officer of this company bought 100,000 shares at a rate of $25.05, taking the stock ownership to the 102,000 shares. Before that another transaction happened on Sep 22 ’25, when Company’s SVP, Finance & CFO sold 4,330 for $35.99, making the entire transaction worth $155,820. This insider now owns 30,079 shares in total.
XOMA Royalty Corp (XOMA) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.06 earnings per share (EPS) during the time that was better than consensus figure (set at -0.3) by 0.24. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 171.97% per share during the next fiscal year.
XOMA Royalty Corp (NASDAQ: XOMA) Trading Performance Indicators
You can see what XOMA Royalty Corp (XOMA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.04. Likewise, its price to free cash flow for the trailing twelve months is 61.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.75, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach 0.89 in one year’s time.
